Suppr超能文献

肝细胞癌局部复发后行挽救性肝切除术,其生存率与接受初次肝切除术的匹配患者相当。

Salvage hepatectomy for local recurrence of hepatocellular carcinomas offers survival comparable to that of matched patients who undergo primary hepatectomies.

作者信息

Kishi Y, Nara S, Esaki M, Hiraoka N, Shimada K

机构信息

Hepatobiliary and Pancreatic Surgery Division, National Cancer Center Hospital, Tokyo, Japan.

Hepatobiliary and Pancreatic Surgery Division, National Cancer Center Hospital, Tokyo, Japan.

出版信息

Eur J Surg Oncol. 2017 Jun;43(6):1076-1082. doi: 10.1016/j.ejso.2017.03.021. Epub 2017 Apr 19.

Abstract

BACKGROUND

The feasibility of salvage hepatectomy for locally recurrent hepatocellular carcinomas (HCCs) is unclear, especially for patients with viable parts of previously multinodular tumors.

METHODS

We reviewed charts of patients who underwent initial hepatectomies between 2000 and 2014 to select those with local recurrences (LR) after non-surgical treatments. Their postoperative outcomes, including morbidity, recurrence-free survival (RFS), and overall survival (OS) were compared with matched patients who underwent initial hepatectomies for primary HCCs (PR). Their local recurrence patterns were divided into recurrent solitary tumors (Subgroup A); and recurrent parts of multinodular tumors (Subgroup B).

RESULTS

Among 664 patients, hepatectomy for LR was performed in 62 patients. Matched 59 patients were selected as PR. Clinicopathologic profiles at initial surgery were comparable between the LR and PR groups. Incidence of major morbidity (LR vs. PR, 7% vs. 5%, P = 1.00), 5-year RFS (21% vs. 37%, P = 0.28), and 5-year OS (69% vs. 69%, P = 0.62) were comparable. In the LR group, Subgroup B showed worse 5-year RFS (A vs. B, 29% vs. 0%, P < 0.01) and 5-year-OS (80% vs. 53%, P = 0.01). Postoperative recurrence occurred in 46 patients, but local and extrahepatic recurrence was seen only in 2 patients and 2 patients, respectively.

CONCLUSION

Salvage hepatectomy for locally recurrent HCCs is feasible, and results in prognosis comparable with hepatectomy for primary HCCs. Although the risk of postoperative recurrence was high in Subgroup B, rare local recurrence suggests the usefulness of salvaging uncontrolled tumor by nonsurgical treatment.

摘要

背景

挽救性肝切除术治疗局部复发性肝细胞癌(HCC)的可行性尚不清楚,尤其是对于先前多结节肿瘤仍有存活部分的患者。

方法

我们回顾了2000年至2014年间接受初次肝切除术患者的病历,以选择那些在非手术治疗后出现局部复发(LR)的患者。将他们的术后结果,包括发病率、无复发生存期(RFS)和总生存期(OS)与接受原发性HCC初次肝切除术(PR)的匹配患者进行比较。他们的局部复发模式分为复发性孤立肿瘤(A组);以及多结节肿瘤的复发部分(B组)。

结果

在664例患者中,62例患者接受了LR肝切除术。选择59例匹配患者作为PR。LR组和PR组初次手术时的临床病理特征具有可比性。严重并发症发生率(LR组与PR组,7%对5%,P = 1.00)、5年RFS(21%对37%,P = 0.28)和5年OS(69%对69%,P = 0.62)具有可比性。在LR组中,B组的5年RFS(A组对B组,29%对0%,P < 0.01)和5年OS(80%对53%,P = 0.01)较差。46例患者术后复发,但仅分别有2例患者出现局部复发和肝外复发。

结论

挽救性肝切除术治疗局部复发性HCC是可行的,其预后与原发性HCC肝切除术相当。尽管B组术后复发风险较高,但罕见的局部复发表明通过非手术治疗挽救未控制肿瘤是有用的。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验